Zusammenfassung
Die Surfactantproteine (SP) A und D sind Collectine, die aus kollagen- und lectinähnlichen Bereichen aufgebaut sind. SP-A und SP-D koordinieren die spezifische und unspezifische Immunantwort der Lunge; im Fruchtwasser und in der Vernix caseosa auf der Haut von Neugeborenen wirken sie als Infektionsschutz. Als Erkennungsmoleküle für Strukturen verschiedener Mikroorganismen vermitteln sie die Opsonierung und Agglutination von Pathogenen, die Chemotaxis von neutrophilen Granulozyten, die Phagozytose von Pathogenen sowie der Bildung von Sauerstoffradikalen im Rahmen der unspezifischen Immunabwehr. Die Wirkung von SP-A und SP-D umfasst darüber hinaus die Interaktion mit T-Lymphozyten, die u. a. zu einer verminderten Interleukin-2-Produktion führt. SP-A und SP-D modulieren die pulmonale Entzündungsreaktion sowohl auf Seiten der unspezifischen als auch der spezifischen Immunabwehr.
Abstract
Surfactant proteins (SP) A and D play a key role in pulmonary host defense of preterm and term newborns. SP-A and SP-D have structural elements of both collagens and lectins, for which they are called ”collectins”. SP-A and SP-D coordinate the innate and adaptive immune response in the lung and convey protection against infection in amniotic fluid and vernix caseosa. They are pattern-recognizing molecules of the innate immune system that are involved in binding, agglutination of pathogens, chemotaxis of neutrophils, phagocytosis of pathogens, and production of reactive oxygen species. In addition, SP-A and SP-D interact with the adaptive immune system by reducing interleukin-2 production and T lymphocyte proliferation.
Schlüsselwörter
Surfactantprotein A und D - Collectine - pulmonale Inflammationsreaktion
Key words
Surfactant protein A and D - collectins - pulmonary inflammation
Literatur
-
1
Speer C P, Halliday H L.
Surfactant therapy in the newborn.
Curr Pediatr.
1994;
4
5-9
-
2
Ikegami M, Jobe A H.
Surfactant protein metabolism in vivo
.
Biochim Biophys Acta.
1998;
1408
218-25
-
3
Jobe A H, Ikegami M.
Biology of surfactant.
Clin Perinatol.
2001;
28
655-69
-
4
Baur F M, Brenner B, Goetze-Speer B, Neu S, Speer C P.
Natural porcine surfactant (Curosurf) down-regulates mRNA of tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha type II receptor in lipopolysaccharide-stimulated monocytes.
Pediatr Res.
1998;
44
32-6
-
5
Speer C P, Götze B, Curstedt T, Robertson B.
Phagocytic functions and tumor necrosis factor secretion of human monocytes exposed to natural porcine surfactant (Curosurf).
Pediatr Res.
1991;
30
69-74
-
6
Speer C P, Robertson B, Halliday H L.
Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?.
Acta Paediatr.
2000;
89
510-2
-
7
Griese M.
Pulmonary surfactant in health and human lung diseases: state of the art.
Eur Respir J.
1999;
13
1455-76
-
8
Corcoran J D, Sheehan O, O’Hara M MT, Halliday H L.
Tracheal surfactant protein-A following treatment with Curosurf.
Appl Cardiopul Pathophysiol.
1995;
5
245-8
-
9
Hallman M, Merrittt T A, Akino T, Bry K.
Surfactant protein-A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid - correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants.
Am Rev Respir Dis.
1991;
144
1376-84
-
10 Burri P W. Developmental and growth of the human lung. In: Fishman AP, Fisher AB, eds Handbook of Physiology: The Respiratory System. Bethesda, MD; American Physiologic Society 1985: 1-46
-
11
Crouch E, Wright J R.
Surfactant proteins A and D and pulmonary host defense.
Annu Rev Physiol.
2001;
63
521-54
-
12
Narendran V, Wickett R P, Pickens W L, Hoath S B.
Interaction between pulmonary surfactant and vernix: a potential mechanism for induction of amniotic fluid turbidity.
Pediatr Res.
2000;
48
120-4
-
13
Hoeger P H, Enzmann C C.
Skin physiology of the neonate and young infant: a prospective study of functional skin parameters during early infancy.
Pediatr Dermatol.
2002;
19
256-62
-
14
Sullivan L C, Daniels C B, Phillips I D, Orgeig S, Whitsett J A.
Conservation of surfactant protein A: evidence for a single origin for vertebrate pulmonary surfactant.
J Mol Evol.
1998;
46
131-8
-
15
Perl A K, Whitsett J A.
Molecular mechanisms controlling lung morphogenesis.
Clin Genet.
1999;
56
14-27
-
16
Crouch E C.
Modulation of host-bacterial interactions by collectins.
Am J Respir Cell Mol Biol.
1999;
21
558-61
-
17
Crouch E, Hartshorn K, Ofek I.
Collectins and pulmonary innate immunity.
Immunol Rev.
2000;
173
52-65
-
18
Mariencheck W I, Savov J, Dong Q, Tino M J, Wright J R.
Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa.
Am J Physiol.
1999;
277
L777-86
-
19
LeVine A M, Kurak K E, Wright J R, Watford W T, Bruno M D, Ross G F, Whitsett J A, Korfhagen T R.
Surfactant protein-A (SP-A) binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A deficient mice.
Am J Respir Mol Cell Biol.
1999;
20
279-86
-
20
Ghildyal R, Hartley C, Varrasso A, Meanger J, Voelker D R, Anders E M, Mills J.
Surfactant protein A binds to the fusion glycoprotein of respiratory syncytial virus and neutralizes virion infectivity.
J Infect Dis.
1999;
180
2009-13
-
21
Patthy L.
Is lung surfactant protein A lectin-collagen hybrid?.
Nature.
1987;
325
490
-
22
Wright J R, Wager R E, Hawgood S, Dobbs L, Clements J A.
Surfactant apoprotein Mr = 26,000 - 36,000 enhances uptake of liposomes by type II cells.
J Biol Chem.
1987;
262
2888-94
-
23
Wright J R.
Immunomodulatory functions of surfactant.
Physiol Rev.
1997;
77
931-62
-
24
Crouch E C.
Collectins and pulmonary host defense.
Am J Respir Cell Mol Biol.
1998;
19
177-201
-
25
van Iwaarden J F, Vanstrijp J AG, Visser H, Haagsman H P, Verhoef J, van Golde L MG.
Binding of surfactant protein A (SP-A) to herpes simplexs virus Type 1-infected cells is mediated by the carbohydrate moiety of SP-A.
J Biol Chem.
1992;
267
25 039-43
-
26
Palaniyar N, Ikegami M, Korfhagen T, Whitsett J, McCormack F X.
Domains of surfactant protein A that affect protein oligomerization, lipid structure and surface tension.
Comp Biochem Physiol A Mol Physiol.
2001;
129
109-27
-
27
Rust K, Grosso L, Zhang V, Chang D, Persson A, Longmore W, Cai G Z, Crouch E.
Human surfactant protein-D: SP-D contains a C-type lectin carbohydrate recognition domain.
Arch Biochem Biophys.
1991;
290
116-26
-
28
Kabha K, Schmegner J, Keisari Y, Parolis H, Schlepper-Schaeffer J, Ofek I.
SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages.
Am J Physiol.
1997;
272
L344-52
-
29
Sano H, Sohma H, Muta T, Momura S, Voelker D R, Kuroki Y.
Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14.
J Immunol.
1999;
164
387-95
-
30
van Rozendaal B A, van Spriel A B, van DeWinkel J G, Haagsman H P.
Role of pulmonary surfactant protein D in innate defense against Candida albicans.
J Infect Dis.
2000;
182
917-22
-
31
Restrepo C I, Dong Q, Savov J, Mariencheck W I, Wright J R.
Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages.
Am J Respir Cell Mol Biol.
1999;
21
576-85
-
32
Madan T, Eggleton P, Kishore U, Strong P, Aggrawal S S, Sarma P U, Reid K BM.
Binding of pulmonary proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages.
Infect Immun.
1997;
65
3171-9
-
33
Hickling T P, Bright H, Wing K, Gower D, Martin S L, Sim R B, Malhotra R.
A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo.
Eur J Immunol.
1999;
29
3478-84
-
34
Wright J R, Borron P, Brinker K G, Folz R J.
Surfactant Protein A: regulation of innate and adaptive immune responses in lung inflammation.
Am J Respir Cell Mol Biol.
2001;
24
513-7
-
35
Yang S, Milla C, Panoskaltsis-Mortari A, Ingbar D H, Blazar B R, Haddad I Y.
Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice.
Am J Respir Cell Mol Biol.
2001;
24
527-36
-
36
Borron P, Veldhuizen R AW, Lewis J E, Possmayer F, Caveney A, Inchley K, Mcfadden R G, Fraher L J.
Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production.
Am J Respir Cell Mol Biol.
1996;
15
115-21
-
37
Borron P, McCormack F X, Elhalwagi B M, Chroneos Z, Lewis J F, Zhu S, Wright J R, Shephard V L, Possmayer F, Inchley K, Fraher L J.
Surfactant protein A inhibits T-cell proliferation via its collagen-like tail and a 210-kDa receptor.
Am J Physiol Lung Cell Mol Physiol.
1998;
275
L679-86
-
38
Borron P J, Crouch E C, Lewis J F, Wright J R, Possmayer F, Fraher L J.
Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production.
J Immunol.
1998;
161
4599-603
-
39
Wang J Y, Shieh C C, You P -F, Lei H -Y, Reid K BM.
Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma.
Am J Respir Crit Care Med.
1998;
158
510-8
-
40
Schelonka R L, Infante A J.
Neonatal immunology.
Semin Perinatol.
1998;
22
2-14
-
41
Jobe A H, Ikegami M.
Mechanisms initiating lung injury in the preterm.
Early Hum Dev.
1998;
53
81-94
-
42 Speer C P, Johnston R B. Neutrophil function in newborn infants. In: Polin RA, Fox WW, eds Fetal and neonatal physiology. Philadelphia; W.B. Saunders 1998: 1954-60
-
43
Stoll B J, Holman R C, Schuchat A.
Decline in sepsis-associated neonatal and infant death the United States, 1979 trough 1994.
Pediatrics.
1998;
102
e18
-
44
Stoll B J, Hansen N, Fanaroff A A, Wright L L, Carlo W A, Ehrenkranz R A, Lemons J A, Donovan E F, Stark AR; Tyson J E, Oh W, Bauer C R, Korones S B, Shankaran S, Laptook A R, Stevenson D K, Papile L A, Poole W K.
Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants.
N Engl J Med.
2002;
347
240-7
-
45
Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S.
Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers.
Chest.
1996;
109
1006-9
-
46
Hawgood S, Ochs M, Jung A, Akiyama J, Allen L, Brown C, Edmondson J, Levitt S, Carlson E, Gillepsie A M, Villar A, Epstein C J, Poulain F R.
Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema.
Am J Physiol Lung Cell Mol Physiol.
2002;
283
L1002-10
-
47
Baughman R P, Sternberg R I, Hull W, Buchsbaum J A, Whitsett J.
Decreased surfactant protein-A in patients with bacterial pneumonia.
Am Rev Respir Dis.
1993;
147
653-7
-
48
Greene K E, Wright J R, Steinberg K P, Ruzinski J T, Caldwell E, Wong W B, Hull W, Whitsett J A, Akino T, Kuroki Y, Nagae H, Hudson L D, Martin T R.
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS.
Am J Respir Crit Care Med.
1999;
160
1843-50
-
49
Hull J, South M, Phelan P, Grimwood K.
Surfactant Composition in infants and young children with cystic fibrosis.
Am J Respir Crit Care Med.
1997;
156
161-5
-
50
Postle A D, Mander A, Reid K B, Wang J Y, Wright S M, Moustaki M, Warner J O.
Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
Am J Respir Cell Mol Biol.
1999;
20
90-8
-
51
Meyer K C, Sharma A, Brown R, Weatherly M, Moya F R, Lewandoski J, Zimmermann J J.
Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
Chest.
2000;
118
164-74
-
52
von Bredow C, Birrer P, Griese M.
Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis.
Eur Respir J.
2001;
17
716-22
-
53
Ratjen F, Doring G, Nikolaizik W H.
Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
Lancet.
2001;
358
983-4
-
54
Khubchandani K R, Oberley R E, Snyder J M.
Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells.
Am J Respir Cell Mol Biol.
2001;
25
699-706
-
55
Korfhagen T R.
Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis.
Am J Respir Cell Mol Biol.
2001;
25
668-72
-
56
Korfhagen T R, Bruno M D, Ross G F, Huelsman K M, Ikegami M, Jobe A H, Wert S E, Stripp B R, Morris R E, Glasser S W, Bachurski C J, Iwamoto H S, Whitsett J A.
Altered surfactant function and strucute in SP-A gene targeted mice.
Proc Natl Acad Sci USA.
1996;
93
9594-9
-
57
Korfhagen T R, Sheftelyevich V, Burhans M S, Bruno M D, Ross G F, Wert S E, Stahlman M T, Jobe A H, Ikegami M, Whitsett J A, Fisher J H.
Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo.
J Biol Chem.
1998;
43
28 438-43
-
58
Fisher J A, Sheftelyevich V, Ho Y -S, Fligiel S, McCormack F X, Korfhagen TR; Whitsett J A, Ikegami M.
Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice.
Am J Physiol.
2000;
278
L365-73
-
59
Botas C, Poulain F, Akiyama J, Brown C, Allen L, Goerke J, Clements J, Carlson E, Gillepsie A M, Epstein C, Hawgood S.
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D.
Proc Natl Acad Sci USA.
1998;
95
11 869-74
-
60
Ikegami M, Korfhagen T R, Bruno M D, Whitsett J A, Jobe A H.
Surfactant metabolism in surfactant protein A-deficient mice.
Amer J Physiol.
1997;
272
L479-85
-
61
Ikegami M, Korfhagen T R, Whitsett J A, Bruno M D, Wert S E, Wada K, Jobe A H.
Characteristics of surfactant from SP-A deficient mice.
Am J Physiol.
1998;
275
L247-58
-
62
Elhalwagi B M, Zhang M, Ikegami M, Iwamoto H S, Morris R E, Miller M L, Dienger K, McCormack F X.
Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A.
Am J Respir Cell Mol Biol.
1999;
21
380-7
-
63
McCormack F X, Whitsett J A.
The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung.
J Clin Invest.
2002;
109
707-12
-
64
Ikegami M, Elhalwagi B M, Palaniyar N, Dienger K, Korfhagen T, Whitsett J A, McCormack F X.
The collagen-like region of surfactant protein A (SP-A) is required for correction of surfactant structural and functional defects in the SP-A null mouse.
J Biol Chem.
2001;
276
38 542-8
-
65
Linke M J, Harris CE; Korfhagen T R, McCormack F X, Ashbaugh A D, Steele P, Whitsett J A, Walzer P D.
Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
J Infect Dis.
2001;
183
943-52
-
66
LeVine A M, Bruno M D, Huelsman K M, Ross G F, Whitsett J A, Korfhagen T R.
Surfactant protein A-deficient mice are susceptible to group B streptococcal infection.
J Immunol.
1997;
158
4336-40
-
67
LeVine A M, Kurak K E, Bruno M D, Stark J, Whitsett J A, Korfhagen T R.
Surfactant protein-A-deficient mice are susceptible to pseudomonas aeruginosa infection.
Am J Respir Mol Cell Biol.
1998;
19
700-8
-
68
LeVine A M, Gwozdz J, Stark J, Bruno M D, Whitsett J A, Korfhagen T R.
Surfactant protein-A enhances respiratory syncytial virus clearance in vivo
.
J Clin Invest.
1999;
103
1015-21
-
69
Bridges J P, Davis H W, Damodarasamy M, Kuroki Y, Howles G, Hui D Y, McCormack F X.
Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury.
J Biol Chem.
2000;
275
38 848-55
-
70
Ikegami M, Whitsett J A, Jobe A H, Ross G, Fisher J, Korfhagen T.
Surfactant metabolism in SP-D gene-targeted mice.
Am J Physiol.
2000;
279
L468-76
-
71
Wert S E, Yoshida M, LeVine A M, Ikegami M, Jones T, Ross G F, Fisher J H, Korfhagen T R, Whitsett J A.
Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice.
Proc Natl Acad Sci USA.
2000;
97
5972-7
-
72
LeVine A M, Whitsett JA; Hartshorn K L, Crouch E C, Korfhagen T R.
Surfactant protein D enhances clearance of influenza A virus from the lung in vivo.
J Immunol.
2001;
167
5868-73
-
73
LeVine A M, Whitsett J A, Gwozdz J A, Richardson T R, Fisher J H, Burhans M S, Korfhagen T R.
Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung.
J Immunol.
2000;
165
3934-40
-
74
Yoshida M, Korfhagen T R, Whitsett J A.
Surfactant protein D regulates, NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways.
J Immunol.
2001;
166
7514-9
Dr. Boris W. Kramer
Universitäts-Kinderklinik
Josef-Schneider-Str. 2
97080 Würzburg
Phone: 0931/201-277728
Fax: 0931/201-27242
Email: b-s.kramer@t-online.de
